Craig Collard - Jan 31, 2025 Form 4 Insider Report for HERON THERAPEUTICS, INC. /DE/ (HRTX)

Role
Chief Executive Officer, Director
Signature
/s/Kathryn Lester Attorney-in-fact for Craig Collard
Stock symbol
HRTX
Transactions as of
Jan 31, 2025
Transactions value $
$0
Form type
4
Date filed
2/4/2025, 12:43 PM
Previous filing
Jan 22, 2025
Next filing
Mar 26, 2025
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction HRTX Employee Stock Option (Right to Buy) Award $0 +1.11M $0.00 1.11M Jan 31, 2025 Common Stock 1.11M $1.70 Direct F1
transaction HRTX Restricted Stock Units Award $0 +557K $0.00 557K Jan 31, 2025 Common Stock 557K $0.00 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The stock option vests and becomes exercisable in 48 equal monthly installments beginning one month after the date of grant (January 31, 2025).
F2 The restricted stock units vest in 16 equal installments beginning one quarter after the date of grant (January 31, 2025).